ISRCTN43724416进行中（未招募）未知
SeconDary Stroke PreVEntion ThRough Pathway ManagemenT (DiVERT Stroke Phase II)
Medtronic (United States)0 个研究点目标入组 1,500 人开始时间: 2022年10月12日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 1,500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Current inclusion criteria as of 23/08/2023:
- •1. Patients with a cryptogenic stroke or large artery atherosclerosis or small vessel occlusion hospitalization between 2023 and 2024
- •2. Age =18 years
- •Previous inclusion criteria:
- •1. Patients with a cryptogenic stroke or large artery atherosclerosis or small vessel occlusion hospitalization between 2022 and 2024
- •2. Age =18 years
排除标准
- •Does not meet inclusion criteria
研究者
相似试验
已完成
不适用
Secondary stroke prevention through pathway managementCirculatory SystemStroke, not specified as haemorrhage or infarctionStrokeISRCTN87407792Medtronic (United States)6,536
招募中
不适用
Prevention of secondary stroke by risk factor control and medication adherenceCTRI/2021/10/037432Department of Health and Family Welfare
已完成
不适用
Stop Stroke: The South London Secondary Prevention ProgrammeCirculatory SystemStrokeISRCTN10730637King's College London (UK)450
已完成
不适用
Evaluation of Secondary Prevention of Stroke Study in the Outpatient Cliniccerebrovascular accident10007963StrokeNL-OMON35302Academisch Medisch Centrum200
进行中（未招募）
不适用
Prevention of one sort of cerebral vascular stroke (small subcortical strokes) in patients who already suffered one beforeEUCTR2005-003242-34-ESational Institutes of Neurological Disorders: Stroke2,500